PBYI FY 2023 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$311M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$236M+3.3% YoY

Gross Profit

$173M73.4% margin

Operating Income

$33M13.9% margin

Net Income

$22M9.2% margin

EPS (Diluted)

$0.45

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$14M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$231M

Total Liabilities

$177M

Stockholders' Equity

$53M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$236M	$228M	+3.3%
Gross Profit	$173M	$173M	+0.0%
Operating Income	$33M	$24M	+37.6%
Net Income	$22M	$2,000	+1079450.0%